Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Toxicology. 2011 Sep 5;287(1-3):99-104. doi: 10.1016/j.tox.2011.06.011. Epub 2011 Jun 23.

Validation of an LDH assay for assessing nanoparticle toxicity.

Author information

  • 1Department of Environmental Medicine, University of Rochester, Rochester, NY, USA. xhan2100@gmail.com

Abstract

Studies showed that certain cytotoxicity assays were not suitable for assessing nanoparticle (NP) toxicity. We evaluated a lactate dehydrogenase (LDH) assay for assessing copper (Cu-40, 40nm), silver (Ag-35, 35nm; Ag-40, 40nm), and titanium dioxide (TiO(2)-25, 25nm) NPs by examining their potential to inactivate LDH and interference with β-nicotinamide adenine dinucleotide (NADH), a substrate for the assay. We also performed a dissolution assay for some of the NPs. We found that the copper NPs, because of their high dissolution rate, could interfere with the LDH assay by inactivating LDH. Ag-35 could also inactivate LDH probably because of the carbon matrix used to cage the particles during synthesis. TiO(2)-25 NPs were found to adsorb LDH molecules. In conclusion, NP interference with the LDH assay depends on the type of NPs and the suitability of the assay for assessing NP toxicity should be examined case by case.

Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

PMID:
21722700
[PubMed - indexed for MEDLINE]
PMCID:
PMC4070602
Free PMC Article

Images from this publication.See all images (7)Free text

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk